{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T12:51:14Z","timestamp":1772628674661,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,18]],"date-time":"2016-04-18T00:00:00Z","timestamp":1460937600000},"content-version":"vor","delay-in-days":17,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100012524","name":"Dutch Federation of University Medical Centers","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012524","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.ijcard.2016.02.003","type":"journal-article","created":{"date-parts":[[2016,2,7]],"date-time":"2016-02-07T03:47:21Z","timestamp":1454816841000},"page":"242-247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["The role of cystatin C as a biomarker for prognosis in pulmonary arterial hypertension due to congenital heart disease"],"prefix":"10.1016","volume":"209","author":[{"given":"Ilja M.","family":"Blok","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annelieke C.M.J.","family":"van Riel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark J.","family":"Schuuring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rianne H.A.C.M.","family":"de Bruin-Bon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arie P.J.","family":"van Dijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elke S.","family":"Hoendermis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aeilko H.","family":"Zwinderman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara J.M.","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berto J.","family":"Bouma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ijcard.2016.02.003_bb0005","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1586\/14779072.2013.811966","article-title":"The challenge of managing pulmonary arterial hypertension in adults with congenital heart disease","volume":"11","author":"Radke","year":"2013","journal-title":"Expert. Rev. Cardiovasc. Ther."},{"key":"10.1016\/j.ijcard.2016.02.003_bb0010","first-page":"270","article-title":"New predictors of mortality in adults with congenital heart disease and pulmonary hypertension: midterm outcome of a prospective study","volume":"181C","author":"Schuuring","year":"2014","journal-title":"Int. J. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2016.02.003_bb0015","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijcard.2006.09.017","article-title":"Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Dutch registry","volume":"120","author":"Duffels","year":"2007","journal-title":"Int. J. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcard.2016.02.003_bb0020","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijcard.2011.06.064","article-title":"Prolonged beneficial effect of bosentan treatment and 4-year survival rates in adult patients with pulmonary arterial hypertension associated with congenital heart disease","volume":"164","author":"Vis","year":"2013","journal-title":"Int. J. Cardiol."},{"issue":"9","key":"10.1016\/j.ijcard.2016.02.003_bb0025","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1056\/NEJMoa1413687","article-title":"Initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension","volume":"373","author":"Gali\u00e8","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2016.02.003_bb0030","doi-asserted-by":"crossref","unstructured":"McLaughlin V V., Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, et al. ACCF\/AHA 2009 expert consensus document on pulmonary hypertension. A report of the American College of Cardiology Foundation Task Force on expert consensus documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J. Am. Coll. Cardiol. American College of Cardiology Foundation; 2009;53(17):1573\u2013619.","DOI":"10.1016\/j.jacc.2009.01.004"},{"key":"10.1016\/j.ijcard.2016.02.003_bb0035","first-page":"ehv317","article-title":"2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","author":"Gali\u00e8","year":"2015","journal-title":"Eur. Heart J."},{"issue":"17","key":"10.1016\/j.ijcard.2016.02.003_bb0040","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1136\/heartjnl-2014-305494","article-title":"C-reactive protein in adults with pulmonary arterial hypertension associated with congenital heart disease and its prognostic value","volume":"100","author":"Scognamiglio","year":"2014","journal-title":"Heart"},{"issue":"3","key":"10.1016\/j.ijcard.2016.02.003_bb0045","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ijcard.2014.04.156","article-title":"Blood biomarkers and their potential role in pulmonary arterial hypertension associated with congenital heart disease. a systematic review","volume":"174","author":"Giannakoulas","year":"2014","journal-title":"Int. J. Cardiol."},{"issue":"6","key":"10.1016\/j.ijcard.2016.02.003_bb0050","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/chd.12022","article-title":"High-sensitivity troponin T is associated with poor outcome in adults with pulmonary arterial hypertension due to congenital heart disease","volume":"8","author":"Schuuring","year":"2013","journal-title":"Congenit. Heart Dis."},{"issue":"9","key":"10.1016\/j.ijcard.2016.02.003_bb0055","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/heartjnl-2011-301522","article-title":"B-type natriuretic peptide concentrations in contemporary Eisenmenger syndrome patients: predictive value and response to disease targeting therapy","volume":"98","author":"Diller","year":"2012","journal-title":"Heart"},{"issue":"4","key":"10.1016\/j.ijcard.2016.02.003_bb0060","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/resp.12259","article-title":"Cystatin C: a potential biomarker for pulmonary arterial hypertension","volume":"19","author":"Fenster","year":"2014","journal-title":"Respirology"},{"issue":"3","key":"10.1016\/j.ijcard.2016.02.003_bb0065","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1053\/j.ajkd.2013.03.027","article-title":"Update on cystatin C: incorporation into clinical practice","volume":"62","author":"Shlipak","year":"2013","journal-title":"Am. J. Kidney Dis."},{"issue":"4","key":"10.1016\/j.ijcard.2016.02.003_bb0070","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/cvr\/cvq208","article-title":"Altered degradation of extracellular matrix in myocardial remodelling: the growing role of cathepsins and cystatins","volume":"87","author":"D\u00edez","year":"2010","journal-title":"Cardiovasc. Res."},{"issue":"5","key":"10.1016\/j.ijcard.2016.02.003_bb0075","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1161\/01.HYP.0000242331.99369.2f","article-title":"Elastolytic cathepsin induction\/activation system exists in myocardium and is upregulated in hypertensive heart failure","volume":"48","author":"Cheng","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2016.02.003_bb0080","first-page":"378","article-title":"Down patients with Eisenmenger syndrome: is bosentan treatment an option?","volume":"134(3)","author":"Duffels","year":"2009"},{"issue":"18","key":"10.1016\/j.ijcard.2016.02.003_bb0085","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1136\/hrt.2010.197509","article-title":"Congenital heart defects are under-recognised in adult patients with Down's syndrome","volume":"96","author":"Vis","year":"2010","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.ijcard.2016.02.003_bb0090","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","article-title":"ATS statement: guidelines for the six-minute walk test","volume":"166","author":"Crapo","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ijcard.2016.02.003_bb0095","first-page":"685","volume":"23(7)","author":"Rudski","year":"2010"},{"issue":"5","key":"10.1016\/j.ijcard.2016.02.003_bb0100","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1515\/CCLM.2009.121","article-title":"Stability of selected serum proteins after long-term storage in the Janus Serum Bank","volume":"47","author":"Gislefoss","year":"2009","journal-title":"Clin. Chem. Lab. Med."},{"issue":"2","key":"10.1016\/j.ijcard.2016.02.003_bb0105","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1161\/CIRCULATIONAHA.106.644286","article-title":"Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the heart and soul study","volume":"115","author":"Ix","year":"2007","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.ijcard.2016.02.003_bb0110","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1093\/eurheartj\/ehl507","article-title":"Prognostic value of cystatin C in acute heart failure in relation to other markers of renal function and NT-proBNP","volume":"28","author":"Lassus","year":"2007","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.ijcard.2016.02.003_bb0115","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jacc.2004.09.061","article-title":"Cystatin-C and mortality in elderly persons with heart failure","volume":"45","author":"Shlipak","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.ijcard.2016.02.003_bb0120","first-page":"404","article-title":"Cystatin C, N-terminal probrain natriuretic peptides and outcomes in acute heart failure with acute kidney injury in a 12-month follow-up: insights into the cardiorenal syndrome","volume":"19","author":"Ruan","year":"2014","journal-title":"J. Res. Med. Sci."},{"issue":"12","key":"10.1016\/j.ijcard.2016.02.003_bb0125","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1053\/euhj.1998.1046","article-title":"Eisenmenger syndrome. factors relating to deterioration and death","volume":"19","author":"Daliento","year":"1998","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2016.02.003_bb0130","first-page":"1","article-title":"Management of patients with pulmonary arterial hypertension due to congenital heart disease: recent advances and future directions","volume":"16","author":"Blok","year":"2015","journal-title":"Expert. Rev. Cardiovasc. Ther."},{"issue":"4","key":"10.1016\/j.ijcard.2016.02.003_bb0135","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.cjca.2014.10.023","article-title":"Adaptation and remodelling of the pulmonary circulation in pulmonary hypertension","volume":"31","author":"Vaillancourt","year":"2015","journal-title":"Can. J. Cardiol."},{"issue":"126","key":"10.1016\/j.ijcard.2016.02.003_bb0140","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1183\/09059180.00004712","article-title":"Pulmonary arterial hypertension associated with congenital heart disease","volume":"21","author":"D'Alto","year":"2012","journal-title":"Eur. Respir. Rev."},{"issue":"11","key":"10.1016\/j.ijcard.2016.02.003_bb0145","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/eurheartj\/eht437","article-title":"Pulmonary hypertension related to congenital heart disease: a call for action","volume":"35","author":"Dimopoulos","year":"2014","journal-title":"Eur. Heart J."},{"issue":"17","key":"10.1016\/j.ijcard.2016.02.003_bb0150","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1136\/heartjnl-2014-305690","article-title":"Survival prospects of treatment na\u00efve patients with Eisenmenger: a systematic review of the literature and report of own experience","volume":"100","author":"Diller","year":"2014","journal-title":"Heart"},{"issue":"2","key":"10.1016\/j.ijcard.2016.02.003_bb0155","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.ijcard.2012.11.052","article-title":"A multi-biomarker risk score improves prediction of long-term mortality in patients with advanced heart failure","volume":"168","author":"Richter","year":"2013","journal-title":"Int. J. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2016.02.003_bb0160","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1161\/01.CIR.80.2.353","article-title":"Two-dimensional and Doppler-echocardiographic and cardiac catheterization correlates of survival in primary pulmonary hypertension","volume":"80","author":"Eysmann","year":"1989","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.ijcard.2016.02.003_bb0165","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1016\/j.jacc.2008.10.001","volume":"52","author":"Warnes","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"issue":"7","key":"10.1016\/j.ijcard.2016.02.003_bb0170","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jacc.2007.04.056","article-title":"Pulmonary arterial thrombosis in Eisenmenger syndrome is associated with biventricular dysfunction and decreased pulmonary flow velocity","volume":"50","author":"Broberg","year":"2007","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316302169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316302169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T12:35:52Z","timestamp":1589632552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527316302169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":34,"alternative-id":["S0167527316302169"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.02.003","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of cystatin C as a biomarker for prognosis in pulmonary arterial hypertension due to congenital heart disease","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 The Authors. Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}